Insider Selling: Immunoprecise Antibodies Ltd (IPA) Insider Sells 245,000 Shares of Stock

Immunoprecise Antibodies Ltd (CVE:IPA) insider Jozef Maria Hendrik Raats sold 245,000 shares of the company’s stock in a transaction that occurred on Friday, November 2nd. The stock was sold at an average price of C$0.81, for a total transaction of C$198,450.00.

Jozef Maria Hendrik Raats also recently made the following trade(s):

  • On Wednesday, October 3rd, Jozef Maria Hendrik Raats sold 6,000 shares of Immunoprecise Antibodies stock. The stock was sold at an average price of C$0.86, for a total transaction of C$5,160.00.
  • On Friday, October 5th, Jozef Maria Hendrik Raats sold 39,500 shares of Immunoprecise Antibodies stock. The stock was sold at an average price of C$0.82, for a total transaction of C$32,390.00.
  • On Tuesday, October 9th, Jozef Maria Hendrik Raats sold 50,000 shares of Immunoprecise Antibodies stock. The stock was sold at an average price of C$0.92, for a total transaction of C$46,000.00.
  • On Friday, August 24th, Jozef Maria Hendrik Raats sold 25,100 shares of Immunoprecise Antibodies stock. The stock was sold at an average price of C$0.99, for a total transaction of C$24,849.00.
  • On Tuesday, August 28th, Jozef Maria Hendrik Raats sold 44,000 shares of Immunoprecise Antibodies stock. The stock was sold at an average price of C$0.99, for a total transaction of C$43,560.00.

IPA stock opened at C$0.83 on Friday. Immunoprecise Antibodies Ltd has a 1-year low of C$0.33 and a 1-year high of C$1.32.

Immunoprecise Antibodies Company Profile

ImmunoPrecise Antibodies Ltd. engages in the antibody production and related services in the United States, Canada, and Europe. The company also provides human antibody development, hybridoma development, genetic immunization, rabbit monoclonal antibody development, recombinant protein expression and production, cryostorage, hybridoma sequencing, antibody generation, antibody purification, polyclonal development, and peptide production services.

Read More: What are the benefits of a balanced fund?

Insider Buying and Selling by Quarter for Immunoprecise Antibodies (CVE:IPA)

Receive News & Ratings for Immunoprecise Antibodies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Immunoprecise Antibodies and related companies with MarketBeat.com's FREE daily email newsletter.


Leave a Reply